Information for the public
Pembrolizumab (Keytruda) with chemoradiotherapy (external beam radiation therapy followed by brachytherapy) is available on the NHS. It is a possible option for untreated International Federation of Gynecology and Obstetrics (FIGO) 2014 stages 3 to 4A locally advanced cervical cancer in adults.
External beam radiation therapy involves a machine moving around the body and directing a beam of radiation to the tumour. Brachytherapy involves placing radioactive material inside the body, close to the tumour.
Is this treatment right for me?
Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. See our webpage on shared decision making.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
The NHS webpage on cervical cancer may be a good place to find out more.
These organisations can give you advice and support:
- UK Cervical Cancer, 0300 0301038
- Cancer Research UK, 0808 800 4040
- Macmillan Cancer Support, 0808 808 0000
You can also get support from your local Healthwatch.
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-9605-6
This page was last updated: